Found: 16
Select item for more details and to access through your institution.
SOHO State of the Art Updates and Next Questions: Waldenström Macroglobulinemia - 2021 Update on Management and Future Directions.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. 347, doi. 10.1016/j.clml.2021.11.014
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions: What is Fitness in the Era of Targeted Agents?
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. 356, doi. 10.1016/j.clml.2021.11.009
- By:
- Publication type:
- Article
The Novel Therapeutic Landscape for Relapsed/Refractory Diffuse Large B Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. 362, doi. 10.1016/j.clml.2021.11.010
- By:
- Publication type:
- Article
Characteristics and Clinical Outcomes of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Who Received At Least 3 Lines of Therapies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. 373, doi. 10.1016/j.clml.2021.11.011
- By:
- Publication type:
- Article
Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. 382, doi. 10.1016/j.clml.2021.11.008
- By:
- Publication type:
- Article
Differential Implications of CSF3R Mutations in t(8;21) and CEBPA Double Mutated Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. 393, doi. 10.1016/j.clml.2021.11.013
- By:
- Publication type:
- Article
The Outcomes of Ponatinib Therapy in Patients With Chronic Myeloid Leukemia Resistant or Intolerant to Previous Tyrosine Kinase Inhibitors, Treated in Poland Within the Donation Program.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. 405, doi. 10.1016/j.clml.2021.11.012
- By:
- Publication type:
- Article
'FLT3 -ITD Mutation Does Not Influence Survival Outcome in Adult Acute Promyelocytic Leukemia Patients Treated With ATO and ATRA-Based Therapeutic Regimen: Experience From a North Indian Tertiary Care Centre'.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. 416, doi. 10.1016/j.clml.2021.12.007
- By:
- Publication type:
- Article
Corrigendum to P-207: A multi-center, phase 1b study to assess the safety, Pharmacokinetics and efficacy of subcutaneous Isatuximab plus Pomalidomide and Dexamethasone, in patients with Relapsed/Refractory Multiple Myeloma [Clinical Lymphoma Myeloma and Leukemia 21 S2 (2021) Pages S152-S153]
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. 424, doi. 10.1016/j.clml.2022.03.009
- By:
- Publication type:
- Article
Corrigendum to "OAB-005: Update of safety and efficacy of Isatuximab short-duration fixed-volume infusion plus Bortezomib, Lenalidomide, and Dexamethasone combined therapy for NDMM ineligible/with no immediate intent for ASCT" [Clinical Lymphoma Myeloma and Leukemia 21 S2 (2021) S3-S4]
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. 425, doi. 10.1016/j.clml.2022.03.010
- By:
- Publication type:
- Article
The Prognostic Significance of c-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. e363, doi. 10.1016/j.clml.2021.11.015
- By:
- Publication type:
- Article
Prognostic significance of CRLF2 overexpression and JAK2 mutation in Egyptian pediatric patients with B-precursor acute lymphoblastic leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. e376, doi. 10.1016/j.clml.2021.12.006
- By:
- Publication type:
- Article
Microsatellite Instability Assessment by Immunohistochemistry in Acute Myeloid Leukemia: A Reappraisal and Review of the Literature.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. e386, doi. 10.1016/j.clml.2021.12.004
- By:
- Publication type:
- Article
An Overview of CAR T Cell Mediated B Cell Maturation Antigen Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. e392, doi. 10.1016/j.clml.2021.12.003
- By:
- Publication type:
- Article
Real-World Evidence of Epidemiology and Clinical Outcomes in Multiple Myeloma, Findings from the Registry of Hemato-Oncologic Malignancies in Colombia, Observational Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. e405, doi. 10.1016/j.clml.2021.12.009
- By:
- Publication type:
- Article
The Application of NextGen Sequencing in the Diagnosis of Myeloid Neoplasms in Myeloma Patients With Cytopenia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. e414, doi. 10.1016/j.clml.2021.12.008
- By:
- Publication type:
- Article